These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6223416)

  • 1. Bone marrow transplantation for severe aplastic anemia using a phenotypically HLA-identical, SB-compatible unrelated donor.
    Duquesnoy RJ; Zeevi A; Marrari M; Hackbarth S; Camitta B
    Transplantation; 1983 Jun; 35(6):566-71. PubMed ID: 6223416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful transplantation of marrow from an HLA-A, -B, -D mismatched heterozygous sibling donor into an HLA-D-homozygous patient with aplastic anemia.
    O'Reilly RJ; Pahwa R; Kirkpatrick D; Sorell M; Kapadia A; Kapoor N; Hansen JA; Pollack M; Schutzer SE; Good RA; Dupont B
    Transplant Proc; 1978 Dec; 10(4):957-62. PubMed ID: 32652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia.
    Hows JM; Yin JL; Marsh J; Swirsky D; Jones L; Apperley JF; James DC; Smithers S; Batchelor JR; Goldman JM
    Blood; 1986 Dec; 68(6):1322-8. PubMed ID: 3535929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage disequilibrium of HLA-SB1 with the HLA-A1, B8, DR3, SCO1 and of HLA-SB4 with the HLA-A26, Bw38, Dw10, DR4, SC21 extended haplotypes.
    Matsui Y; Alosco SM; Awdeh Z; Duquesnoy RJ; Page PL; Hartzman RJ; Alper CA; Yunis EJ
    Immunogenetics; 1984; 20(6):623-31. PubMed ID: 6239824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of IgA deficiency to a bone-marrow-grafted patient with aplastic anaemia.
    Hammarström L; Lönnqvist B; Ringdén O; Smith CI; Wiebe T
    Lancet; 1985 Apr; 1(8432):778-81. PubMed ID: 2858666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor.
    Lohrmann HP; Dietrich M; Goldmann SF; Kristensen T; Fliedner TM; Abt C; Pflieger H; Flad HD; Kubanek B; Heimpel H
    Blut; 1975 Dec; 31(6):347-54. PubMed ID: 1127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed lymphocyte reactions for individuals with phenotypic identity for specific HLA-B,DR determinants: the role of linkage disequilibrium and of specific DR and other class II determinants.
    Pollack MS; Chin-Louie J; Callaway C; Blanco MA; Slavin K; Sullivan K; O'Reilly RJ; Dupont B
    J Clin Immunol; 1983 Oct; 3(4):341-51. PubMed ID: 6197424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
    Chu E; Umetsu D; Rosen F; Geha RS
    J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic stem cell transplantation in children with aplastic anemia.
    Xue HM; Xu HG; Huang K; Guo HX; Li Y; Zhou DH; Huang SL; Fang JP; Chen C
    Genet Mol Res; 2015 May; 14(2):5234-45. PubMed ID: 26125718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party.
    Bacigalupo A; Hows J; Gordon-Smith EC; Gluckman E; Van Lint MT; Congiu M; James DC; Barrett AJ; Gmur J; De Planque MM
    Bone Marrow Transplant; 1988 Nov; 3(6):531-5. PubMed ID: 3063321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of antithymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host disease.
    Filipovich AH; Ramsay NK; Arthur DC; McGlave P; Kim T; Kersey JH
    Transplantation; 1985 Mar; 39(3):282-5. PubMed ID: 3156437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and results of bone marrow transplantation from an HLA-mismatched unrelated donor for children and young adults with acquired severe aplastic anemia.
    Yagasaki H; Takahashi Y; Kudo K; Ohashi H; Hama A; Yamamoto T; Tanaka M; Yoshida N; Hidaka H; Nishio N; Kojima S
    Int J Hematol; 2007 Jun; 85(5):437-42. PubMed ID: 17562622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
    Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A
    Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia--a single-center experience.
    Wang H; Wang Z; Zheng X; Ding L; Zhu L; Yan H; Guo Z
    Cytotherapy; 2013 Sep; 15(9):1118-25. PubMed ID: 23806238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization.
    Tiercy JM; Morel C; Freidel AC; Zwahlen F; Gebuhrer L; Bétuel H; Jeannet M; Mach B
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7121-5. PubMed ID: 1908088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure.
    Gajewski JL; Ho WG; Feig SA; Hunt L; Kaufman N; Champlin RE
    Transplantation; 1990 Aug; 50(2):244-9. PubMed ID: 2143325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.
    Arai Y; Kondo T; Yamazaki H; Takenaka K; Sugita J; Kobayashi T; Ozawa Y; Uchida N; Iwato K; Kobayashi N; Takahashi Y; Ishiyama K; Fukuda T; Ichinohe T; Atsuta Y; Mori T; Teshima T;
    Haematologica; 2016 May; 101(5):644-52. PubMed ID: 26858357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous marrow recovery and sensitization to non-HLA antigens after HLA-identical marrow transplantation for aplastic anemia.
    Tsoi MS; Warren RP; Storb R; Witherspoon RP; Mickelson E; Giblett ER; Schanfield MS; Weiden P; Thomas ED
    Exp Hematol; 1983 Jan; 11(1):73-81. PubMed ID: 6219886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone-marrow transplantation for severe aplastic anaemia using histocompatible unrelated volunteer donors.
    Gordon-Smith EC; Fairhead SM; Chipping PM; Hows J; James DC; Dodi A; Batchelor JR
    Br Med J (Clin Res Ed); 1982 Sep; 285(6345):835-7. PubMed ID: 6214294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
    Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
    Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.